News
PRE
5.81
-1.19%
-0.07
Weekly Report: what happened at PRE last week (0106-0110)?
Weekly Report · 2d ago
Weekly Report: what happened at PRE last week (1230-0103)?
Weekly Report · 01/06 11:29
Weekly Report: what happened at PRE last week (1223-1227)?
Weekly Report · 12/30/2024 11:23
Weekly Report: what happened at PRE last week (1216-1220)?
Weekly Report · 12/23/2024 11:30
Prenetics’ IM8 enters collaboration with Mayo Clinic to develop supplement line
TipRanks · 12/19/2024 13:41
Prenetics' IM8 Announces Collaboration With Mayo Clinic To Develop New Line Of Premium Supplements To Focus On Nutrition, Cellular Rejuvenation, Protein, Collagen And Overall Wellness
Benzinga · 12/19/2024 13:41
Weekly Report: what happened at PRE last week (1209-1213)?
Weekly Report · 12/16/2024 11:30
Prenetics Global Announces 2024 Annual General Meeting
TipRanks · 12/13/2024 13:47
Weekly Report: what happened at PRE last week (1202-1206)?
Weekly Report · 12/09/2024 11:29
IM8 Partners with University of Oxford for Groundbreaking Space Experiment on Aging Aboard the ISS
Barchart · 12/05/2024 17:52
Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Incyte (INCY) and Prenetics Group (PRE)
TipRanks · 12/05/2024 16:02
Prenetics’ IM8, University of Oxford begin space experiment
TipRanks · 12/05/2024 13:45
Prenetics' IM8 And University Of Oxford Launch Space Experiment On ISS To Study Accelerated Aging And Longevity
Benzinga · 12/05/2024 13:34
Prenetics Global Price Target Maintained With a $9.00/Share by Cantor Fitzgerald
Dow Jones · 12/04/2024 16:11
Cantor Fitzgerald Reiterates Overweight on Prenetics Global, Maintains $9 Price Target
Benzinga · 12/04/2024 16:04
Prenetics Announces Participation in December Investor Conferences
Barchart · 12/04/2024 15:05
Weekly Report: what happened at PRE last week (1125-1129)?
Weekly Report · 12/02/2024 11:29
Prenetics Global Limited Reports 59.4% Revenue Growth and Launches Premium Supplement Brand IM8Health.com
Barchart · 11/27/2024 17:52
Prenetics Global Q3 Loss Narrows On Surge In Revenue
NASDAQ · 11/27/2024 14:40
Prenetics Reports Strong Growth with New Launches
TipRanks · 11/27/2024 13:57
More
Webull provides a variety of real-time PRE stock news. You can receive the latest news about Prenetics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRE
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.